• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缓解-复发的临床病程扩大了 Aicardi-Goutières 综合征的表型。

Relapsing-remitting clinical course expands the phenotype of Aicardi-Goutières syndrome.

机构信息

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

出版信息

Ann Clin Transl Neurol. 2020 Feb;7(2):254-258. doi: 10.1002/acn3.50979. Epub 2020 Jan 10.

DOI:10.1002/acn3.50979
PMID:31920009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7034496/
Abstract

Aicardi-Goutières syndrome (AGS) is a rare and likely underdiagnosed genetic leukoencephalopathy, typically presenting in infancy with encephalopathy and characteristic neuroimaging features, with residual static neurological deficits. We describe a patient who, following an initial presentation at the age of 12 months in keeping with AGS, exhibited a highly atypical relapsing course of neurological symptoms in adulthood with essentially normal neuroimaging. Whole-exome sequencing confirmed a pathogenic RNASEH2B gene variant consistent with AGS. This case highlights the expanding phenotypes associated with AGS and the potential role of whole-exome sequencing in facilitating an increase in the rate of diagnosis.

摘要

Aicardi-Goutières 综合征(AGS)是一种罕见且可能诊断不足的遗传性脑白质病,通常在婴儿期表现为脑病和特征性神经影像学特征,伴有残留的静态神经功能缺损。我们描述了一位患者,其在 12 个月大时首次出现符合 AGS 的表现,随后在成年期表现出高度非典型的复发性神经症状,神经影像学基本正常。全外显子组测序证实存在 RNASEH2B 基因变异,与 AGS 一致。该病例强调了与 AGS 相关的表型不断扩大,以及全外显子组测序在提高诊断率方面的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc7b/7034496/421c6864fa0c/ACN3-7-254-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc7b/7034496/421c6864fa0c/ACN3-7-254-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc7b/7034496/421c6864fa0c/ACN3-7-254-g001.jpg

相似文献

1
Relapsing-remitting clinical course expands the phenotype of Aicardi-Goutières syndrome.缓解-复发的临床病程扩大了 Aicardi-Goutières 综合征的表型。
Ann Clin Transl Neurol. 2020 Feb;7(2):254-258. doi: 10.1002/acn3.50979. Epub 2020 Jan 10.
2
p.Arg69Trp in RNASEH2C is a founder variant in three Indian families with Aicardi-Goutières syndrome.RNASEH2C基因中的p.Arg69Trp是三个患有Aicardi-Goutières综合征的印度家族中的始祖变异。
Am J Med Genet A. 2018 Jan;176(1):156-160. doi: 10.1002/ajmg.a.38522. Epub 2017 Nov 17.
3
Late diagnosis and atypical brain imaging of Aicardi-Goutières syndrome: are we failing to diagnose Aicardi-Goutières syndrome-2?艾卡迪-古铁雷斯综合征的延迟诊断与非典型脑成像:我们是否未能诊断出艾卡迪-古铁雷斯综合征2型?
Dev Med Child Neurol. 2017 Dec;59(12):1307-1311. doi: 10.1111/dmcn.13509. Epub 2017 Aug 1.
4
Combination of exome sequencing and immune testing confirms Aicardi-Goutières syndrome type 5 in a challenging pediatric neurology case.外显子组测序与免疫检测相结合确诊了一例具有挑战性的儿科神经病例中的5型艾卡迪-古铁雷斯综合征。
Cold Spring Harb Mol Case Stud. 2018 Oct 1;4(5). doi: 10.1101/mcs.a002758. Print 2018 Oct.
5
Case Report: Novel Compound Heterozygous Mutations Cause Aicardi-Goutières Syndrome.病例报告:新型复合杂合突变导致 Aicardi-Goutières 综合征。
Front Immunol. 2021 Apr 26;12:672952. doi: 10.3389/fimmu.2021.672952. eCollection 2021.
6
Chronic Encephalopathy, Startle, and Intracranial Calcification: Think Beyond Intrauterine Infections.
Pediatr Neurol. 2019 Aug;97:78-79. doi: 10.1016/j.pediatrneurol.2019.01.014. Epub 2019 Jan 30.
7
Late-Onset Aicardi-Goutières Syndrome: A Characterization of Presenting Clinical Features.迟发性 Aicardi-Goutières 综合征:临床表现特征的描述。
Pediatr Neurol. 2021 Feb;115:1-6. doi: 10.1016/j.pediatrneurol.2020.10.012. Epub 2020 Nov 2.
8
Systemic inflammation and chronic kidney disease in a patient due to the RNASEH2B defect.RNASEH2B 缺陷导致的系统性炎症和慢性肾脏病患者。
Pediatr Rheumatol Online J. 2021 Jan 22;19(1):9. doi: 10.1186/s12969-021-00497-2.
9
Spontaneous MRI improvement and absence of cerebral calcification in Aicardi-Goutières syndrome: Diagnostic and disease-monitoring implications.Aicardi-Goutières 综合征的自发 MRI 改善和无脑钙化:诊断和疾病监测意义。
Mol Genet Metab. 2019 Apr;126(4):489-494. doi: 10.1016/j.ymgme.2019.02.006. Epub 2019 Feb 25.
10
Bilateral striatal necrosis in two subjects with Aicardi-Goutières syndrome due to mutations in ADAR1 (AGS6).两名 Aicardi-Goutières 综合征(AGS6)患者因 ADAR1(AGS6)基因突变导致双侧纹状体坏死。
Am J Med Genet A. 2014 Mar;164A(3):815-9. doi: 10.1002/ajmg.a.36360. Epub 2013 Dec 20.

引用本文的文献

1
Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib.托西珠单抗可降低接受鲁索利替尼治疗的 7 型 Aicardi-Goutières 综合征患者难以控制的炎症反应。
Pediatr Rheumatol Online J. 2023 Oct 12;21(1):117. doi: 10.1186/s12969-023-00899-4.

本文引用的文献

1
Treatments in Aicardi-Goutières syndrome.Aicardi-Goutières 综合征的治疗方法。
Dev Med Child Neurol. 2020 Jan;62(1):42-47. doi: 10.1111/dmcn.14268. Epub 2019 Jun 7.
2
Spontaneous MRI improvement and absence of cerebral calcification in Aicardi-Goutières syndrome: Diagnostic and disease-monitoring implications.Aicardi-Goutières 综合征的自发 MRI 改善和无脑钙化:诊断和疾病监测意义。
Mol Genet Metab. 2019 Apr;126(4):489-494. doi: 10.1016/j.ymgme.2019.02.006. Epub 2019 Feb 25.
3
Recurrent Encephalopathy with Spinal Cord Involvement: An Atypical Manifestation of Aicardi-Goutières Syndrome.
伴有脊髓受累的复发性脑病:Aicardi-Goutières综合征的非典型表现。
Ann Indian Acad Neurol. 2019 Jan-Mar;22(1):111-115. doi: 10.4103/aian.AIAN_12_18.
4
Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome.艾卡迪-古铁雷斯综合征中的逆转录酶抑制剂
N Engl J Med. 2018 Dec 6;379(23):2275-7. doi: 10.1056/NEJMc1810983.
5
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.巴瑞替尼治疗自身炎症性干扰素病的 JAK1/2 抑制作用。
J Clin Invest. 2018 Jul 2;128(7):3041-3052. doi: 10.1172/JCI98814. Epub 2018 Jun 11.
6
An open-label trial of JAK 1/2 blockade in progressive -associated neuroinflammation.一项关于JAK 1/2阻断剂在进行性相关神经炎症中的开放标签试验。
Neurology. 2018 Feb 6;90(6):289-291. doi: 10.1212/WNL.0000000000004921. Epub 2018 Jan 10.
7
Variable clinical phenotype in two siblings with Aicardi-Goutières syndrome type 6 and a novel mutation in the ADAR gene.两例 Aicardi-Goutières 综合征 6 型患儿的可变临床表型和 ADAR 基因突变。
Eur J Paediatr Neurol. 2018 Jan;22(1):186-189. doi: 10.1016/j.ejpn.2017.11.003. Epub 2017 Nov 22.
8
Late diagnosis and atypical brain imaging of Aicardi-Goutières syndrome: are we failing to diagnose Aicardi-Goutières syndrome-2?艾卡迪-古铁雷斯综合征的延迟诊断与非典型脑成像:我们是否未能诊断出艾卡迪-古铁雷斯综合征2型?
Dev Med Child Neurol. 2017 Dec;59(12):1307-1311. doi: 10.1111/dmcn.13509. Epub 2017 Aug 1.
9
Aicardi-Goutières syndrome: unusual neuro-radiological manifestations.艾卡迪-古铁雷斯综合征:不寻常的神经放射学表现。
Metab Brain Dis. 2017 Jun;32(3):679-683. doi: 10.1007/s11011-017-9993-4. Epub 2017 Mar 23.
10
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children.Janus激酶1/2抑制剂芦可替尼治疗3例与TMEM173激活突变相关的血管病变患儿的疗效
J Allergy Clin Immunol. 2016 Dec;138(6):1752-1755. doi: 10.1016/j.jaci.2016.07.015. Epub 2016 Aug 20.